Medical Cannabis for Alzheimer’s Disease
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDAnxietySleepNeurologyResearchAgingMental Health Why This Matters Clinicians managing Alzheimer’s disease…
ASX 200 Cannabis Stocks Shift Toward Clinical Proof
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustrySafetyPainAnxietyMental Health Clinical Summary # Clinical Summary The Australian cannabis industry…
CMS Opened the Door for Cannabinoids. ACOs Still Need the Operating Model
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyCBDTHCSafetyResearchIndustryMental Health Why This Matters Accountable Care Organizations now face a critical…
Prevalence of cannabis, alcohol, and simultaneous use among drivers in states with and …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyTHCMental HealthNeurologyIndustry Why This Matters # Clinical SignificanceClinicians need to…
Swiss Canton St Gallen Launches Large-Scale Cannabis Study
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyTHCCBDHempIndustry Why This Matters This large-scale Swiss study will generate rigorous evidence on…
Study shows branding on cannabis products appeals to youth – News-Medical.Net
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryPediatricsPainAnxiety Why This Matters Clinicians need to understand that aggressive product…
Medical Cannabis Linked to Meaningful Pain-Related Improvements in Large Minnesota Study
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainTHCCBDResearchSafetyPolicyAnxiety Why This Matters Clinicians treating chronic pain patients need this data because…
Exilby: Europe’s First Standardized Cannabis Medicine Approved
Exilby marks a milestone as the first standardized cannabis medicine Europe has approved. This pharmaceutical-grade product offers consistent THC dosing unlike unregulated cannabis. Clinicians can now consider Exilby for safer, predictable therapeutic…
Germany Approves First Standardised Cannabis Painkiller as Alternative to Opioids
✦ New CED Clinical Relevance #80 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainPolicyIndustryResearchSafetyTHCCBD Why This Matters This approval provides clinicians with a regulated,…
Governor Ayotte vetoes bipartisan bill to expand cultivation of medicinal marijuana
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyIndustryPainAnxietyMental HealthSafetyResearch Why This Matters Vetoing this cultivation expansion bill delays…